Natco Pharma receives Establishment Inspection Report for Kothur facility

16 Aug 2016 Evaluate

Natco Pharma has received successful Establishment Inspection Report (EIR) during the period February 29 to March 7, 2016 from the U.S. Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility in Kothur Village, Mahaboob Nagar District, India. The Kothur facility predominantly caters to regulated international markets, including USA. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

903.00 5.95 (0.66%)
31-Dec-2025 13:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1270.20
Cipla 1505.70
Zydus Lifesciences 913.05
Lupin 2109.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×